Background pattern

Aimovig 140 mg soluciÓn inyectable en pluma precargada

About the medicine

About the medication

Introduction

Prospect: information for the user

Aimovig 70 mg injectable solution in pre-filled pen

Aimovig 140 mg injectable solution in pre-filled pen

erenumab

Read this prospect carefully before starting to use this medicine, because it contains important information for you.

  • Keep this prospect, as you may need to read it again.
  • If you have any questions, consult your doctor, pharmacist, or nurse.
  • This medicine has been prescribed only for you, and you must not give it to other people even if they have the same symptoms as you, as it may harm them.
  • If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they do not appear in this prospect. See section 4.

1. What is Aimovig and what is it used for

Aimovig contains the active ingredient erenumab. It belongs to a group of medicines called monoclonal antibodies.

Aimovig acts by blocking the activity of the CGRP molecule, which has been linked to migraine (CGRP are the English initials for calcitonin gene-related peptide).

Aimovig is used to prevent migraine in adults who have at least 4 days of migraine per month at the start of treatment with Aimovig.

2. What you need to know before starting to use Aimovig

No use Aimovig

  • if you are allergic to erenumab or any of the other ingredients in this medication (listed in section 6).

Warnings and precautions

Consult your doctor before starting to use Aimovig:

  • if you have ever had an allergic reaction to latex rubber. The packaging of this medication contains latex rubber in the cap.
  • if you have a cardiovascular disease. Aimovig has not been studied in patients with certain cardiovascular diseases.

Consult your doctor or seek immediate medical help:

-if you have any symptoms of a severe allergic reaction, such as rash or inflammation typically of the face, mouth, tongue, or throat; or difficulty breathing. Severe allergic reactions can occur within minutes of using Aimovig, but some may occur more than a week after.

  • contact your doctor if you have constipation and seek immediate medical help if you develop severe and persistent abdominal pain or vomiting, abdominal inflammation or swelling. Constipation may occur with Aimovig treatment. It is usually mild or moderate in intensity. However, some patients who have used Aimovig have had severe constipation that required hospitalization.Some cases have required surgical intervention.

Children and adolescents

This medication should not be administered to children or adolescents (under 18 years) as it has not been studied in this age group.

Other medications and Aimovig

Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor before using this medication.

Pregnancy

Your doctor will decide whether you should stop using Aimovig during pregnancy.

Breastfeeding

Monoclonal antibodies like Aimovig are known to pass into breast milk during the first few days after birth, but after this initial period, Aimovig can be used. Consult your doctor about using Aimovig during breastfeeding to help you decide whether to stop breastfeeding or stop using Aimovig.

Driving and operating machinery

Aimovig is unlikely to affect your ability to drive and use machines.

Aimovig contains sodium

Aimovig contains less than 1 mmol of sodium (23 mg) per dose; it is essentially “sodium-free”.

3. How to Use Aimovig

Follow exactly the administration instructions for this medication as indicated by your doctor. If in doubt, consult your doctor again.

If your doctor prescribes a dose of 70 mg, you should administer one injection every 4 weeks. If your doctor prescribes a dose of 140 mg, you should administer one injection of Aimovig 140 mg or two consecutive injections of Aimovig 70 mg, every 4 weeks. If two injections of Aimovig 70 mg are administered, the second injection should be administered immediately after the first, in a different injection site. Make sure to inject the entire contents of both pens.

Aimovig is administered as a subcutaneous injection under the skin. You or your caregiver can administer the injection in the abdomen or thigh. The outer area of the upper arm can also be used as an injection site, but only if someone else is administering the injection. If you need 2 injections, they should be administered in different locations to avoid skin hardening and should not be administered in areas where the skin is sensitive, damaged, red, or hardened.

Your doctor or nurse will teach you or your caregiver how to properly prepare and administer Aimovig. Do not attempt to administer Aimovig until you have received this training.

If you have not noticed any effect from the treatment after 3 months, inform your doctor, who will decide whether to continue treatment.

Aimovig pens are for single use only.

You can consult the detailed instructions on how to administer Aimovig in the "Aimovig Pre-Filled Pen User Instructions" section at the end of this leaflet.

If you use more Aimovig than you should

If you have received more Aimovig than you should or if the dose has been administered earlier than it should have been, inform your doctor.

If you forget to use Aimovig

  • If you forget a dose of Aimovig, administer it as soon as you remember.
  • Then contact your doctor, who will tell you when to administer the next dose. Follow the new schedule exactly as your doctor instructs.

If you interrupt treatment with Aimovig

Do not interrupt treatment with Aimovig without first speaking with your doctor. If you interrupt treatment, your symptoms may reappear.

If you have any other questions about the use of this medication, ask your doctor, pharmacist, or nurse.

4. Possible Adverse Effects

Like all medications, this medication may produce adverse effects, although not all people may experience them.

The following are possible adverse effects. Most of these effects are mild to moderate in nature.

Frequent: may affect up to 1 in 10 patients

  • Allergic reactions such as rash, swelling, urticaria, or difficulty breathing (see section2)
  • Constipation
  • Itching
  • Muscle spasms
  • Reactions at the injection site, such as pain, redness, and swelling at the site where the injection is administered.

Unknown frequency (cannot be estimated from available data)

-Skin reactions such as rash, itching, hair loss, or sores in the mouth or lip.

Reporting Adverse Effects

If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through the national notification system included in theAppendix V. By reporting adverse effects, you can contribute to providing more information about the safety of this medication.

5. Conservation of Aimovig

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the label after EXP and on the box after CAD. The expiration date is the last day of the month indicated.

Store the pen in the outer packaging to protect it from light. Store in the refrigerator (between 2°C and 8°C). Do not freeze.

Once Aimovig has been removed from the refrigerator, it must be stored at room temperature (up to 25°C) in the outer packaging and must be used within a maximum of 7 days, or otherwise discard it. Once Aimovig has been removed from the refrigerator, it should not be returned.

Do not use this medication if you observe that the solution contains particles, is cloudy, or has a clearly yellow color.

Medicines should not be thrown away through drains. Ask your pharmacist how to dispose of the containers and medications that you no longer need. There may be local regulations for disposal. By doing so, you will help protect the environment.

6. Contents of the packaging and additional information

Composition of Aimovig

  • The active ingredient is erenumab.
  • Aimovig 70 mg pre-filled syringe contains 70 mg of erenumab.
  • Aimovig 140 mg pre-filled syringe contains 140 mg of erenumab.
  • The other components are sucrose, polysorbate 80, sodium hydroxide, glacial acetic acid, and water for injection.

Appearance of the product and contents of the pack

Aimovig solution for injection is transparent to opalescent, colourless to pale yellow and practically free from particles.

Aimovig is available in packs containing a pre-filled syringe for single use and in multiple packs containing 3 (3x1) pre-filled syringes.

Only some pack sizes may be marketed.

Marketing authorisation holder

Novartis Europharm Limited

Vista Building

Elm Park, Merrion Road

Dublin 4

Ireland

Manufacturer responsible

Sandoz GmbH

Biochemiestrasse 10

6336 Langkampfen

Austria

Novartis Pharma GmbH

Roonstrasse 25

90429 Nuremberg

Germany

Novartis Pharmaceutical Manufacturing GmbH

Biochemiestrasse 10

6336 Langkampfen

Austria

For further information about this medicinal product, please consult the representative of the marketing authorisation holder in your country:

België/Belgique/Belgien

Novartis Pharma N.V.

Tél/Tel: +32 2 246 16 11

Lietuva

SIA Novartis Baltics Lietuvos filialas

Tel: +370 5 269 16 50

????????

Novartis Bulgaria EOOD

???: +359 2 489 98 28

Luxembourg/Luxemburg

Novartis Pharma N.V.

Tél/Tel: +32 2 246 16 11

Ceská republika

Novartis s.r.o.

Tel: +420 225 775 111

Magyarország

Novartis Hungária Kft.

Tel.: +36 1 457 65 00

Danmark

Novartis Healthcare A/S

Tlf: +45 39 16 84 00

Malta

Novartis Pharma Services Inc.

Tel: +356 2122 2872

Deutschland

Novartis Pharma GmbH

Tel: +49 911 273 0

Nederland

Novartis Pharma B.V.

Tel: +31 88 04 52 111

Eesti

SIA Novartis Baltics Eesti filiaal

Tel: +372 66 30 810

Norge

Novartis Norge AS

Tlf: +47 23 05 20 00

Ελλ?δα

Novartis (Hellas) A.E.B.E.

Τηλ: +30 210 281 17 12

Österreich

Novartis Pharma GmbH

Tel: +43 1 86 6570

España

Novartis Farmacéutica, S.A.

Tel: +34 93 306 42 00

Polska

Novartis Poland Sp. z o.o.

Tel.: +48 22 375 4888

France

Novartis Pharma S.A.S.

Tél: +33 1 55 47 66 00

Portugal

Novartis Farma - Produtos Farmacêuticos, S.A.

Tel: +351 21 000 8600

Hrvatska

Novartis Hrvatska d.o.o.

Tel. +385 1 6274 220

România

Novartis Pharma Services Romania SRL

Tel: +40 21 31299 01

Ireland

Novartis Ireland Limited

Tel: +353 1 260 12 55

Slovenija

Novartis Pharma Services Inc.

Tel: +386 1 300 75 50

Ísland

Vistor hf.

Sími: +354 535 7000

Slovenská republika

Novartis Slovakia s.r.o.

Tel: +421 2 5542 5439

Italia

Novartis Farma S.p.A.

Tel: +39 02 96 54 1

Suomi/Finland

Novartis Finland Oy

Puh/Tel: +358 (0)10 6133 200

Κ?προς

Novartis Pharma Services Inc.

Τηλ: +357 22 690 690

Sverige

Novartis Sverige AB

Tel: +46 8 732 32 00

Latvija

SIA Novartis Baltics

Tel: +371 67 887 070

United Kingdom (Northern Ireland)

Novartis Ireland Limited

Tel: +44 1276 698370

Last update of this leaflet:

Other sources of information

Further information about this medicinal product is available on the website of the European Medicines Agency:http://www.ema.europa.eu

Instructions for use of Aimovig pre-filled syringes

Scheme of the Aimovig 70 mg syringe(with a blue clear body, violet start button, white cap and green safety guard)

Scheme of the Aimovig 140 mg syringe(with a dark blue body, grey start button, orange cap and yellow safety guard)

Step 1: Preparation

Nota: The dose of Aimovig prescribed to you is either 70 mg or 140 mg. This means that for a dose of 70 mg, you need to inject the contents of a single-use 70 mg syringe. For a dose of 140 mg, you need to inject the contents of a single-use 140 mg syringe or two single-use 70 mg syringes consecutively.

(A)

Remove the pre-filled syringe(s) from the pack. Depending on the dose prescribed to you, you may need to use one or two syringes. Do not shake.

To avoid any discomfort at the injection site, keep the syringe(s) at room temperature for at least 30 minutes before injection.

Nota: Do not try to heat the syringe using a heat source such as hot water or a microwave.

(B)

Visually inspect the syringe(s). Make sure the solution you see through the window is transparent and colourless or pale yellow.

Nota:

  • Do not use the syringe if any component is cracked or broken.
  • Do not use any syringe that has fallen.
  • Do not use the syringe if the cap is missing or not securely attached.

Use a new syringe in all the above cases and if you have any doubts, contact your doctor or pharmacist.

(C)

Assemble all the necessary materials for the injection(s).

Wash your hands thoroughly with soap and water.

On a clean and well-lit work surface, place:

  • New syringe(s)
  • Alcohol wipes
  • Cotton balls or gauze
  • Adhesive bandages (band-aids)
  • Sharps container

(D)

Prepare and clean the injection site(s).

Only use the following injection sites:

  • Thigh
  • Abdomen (except a 5 cm area around the navel)
  • Outer area of the upper arm (only if someone else is to administer the injection)

Clean the injection site with an alcohol wipe and let the skin dry.

Choose a different site each time you need an injection. If you need to use the same site, make sure it is not the same spot as the previous injection.

Nota:

  • After cleaning the site, do not touch it again before the injection.
  • Do not choose a site where the skin is sensitive, damaged, red or hardened. Avoid injecting in areas with scars or stretch marks.

Step 2: Prepare

(E)

Once you are ready for the injection (not before), remove the cap by pulling it straight out. From this point on, the injection must be administeredwithin a maximum of 5 minutes. It is normal to see a drop of liquid at the tip of the needle or safety guard.

Nota:

  • Do not leave the cap out for more than 5 minutes, as the medicine may dry out.
  • Do not turn or bend the cap.
  • Do not put the cap back on the syringe after removing it.
  • Do not put your fingers inside the safety guard.

(F)

Prepare a firm surfaceat the chosen injection site (thigh, abdomen or outer area of the upper arm), usingeitherthe Stretching methodorthe Pinch method.

Stretching method

Stretch the skin firmly by moving your thumb and other fingers in opposite directions to define an area ofabout 5 centimeterswide.

Pinch method

Pinch the skin firmly between your thumb and other fingers to define an area ofabout 5 centimeterswide.

Nota: It is essential to keep the skin stretched or pinched while injecting.

Step 3: Injection

(G)

Keep the skin stretched/pinched. Having removed the cap, placethe safety guard of the syringe on the skin at a 90-degree angle.The needle is inside the safety guard.

Nota: You have not yet touched the start button.

(H)

Press the syringe firmly onto the skin until it will not advance any further.

Nota: You must press as much as possible but do not touch the start button until you are ready to inject.

(I)

Press the start button. You will hear a “click”.

(J)

Release the start button, but keep the syringe pressed onto the skin. The injection may take about 15 seconds.

Nota: When the injection is finished, the window will change from transparent to yellow and you may hear a second “click”.

Nota:

  • When you remove the syringe from the skin, the needle will be automatically covered by the safety guard.
  • If, when removing the syringe, the window is not yellow or appears to be still injecting medicine, this means you have not received a full dose. Contact your doctor immediately.

Step 4: Final

(K)

Dispose of the used syringe and cap.

Deposit the used syringe in a sharps container immediately after use. Consult your doctor or pharmacist about the correct disposal. There may be local regulations.

Nota:

  • Do not reuse the syringe.
  • Do not recycle the syringe or sharps container.
  • Always keep the sharps container out of reach of children.

(L)

Examine the injection site.

If there is blood on the skin, press a cotton ball or gauze onto the injection site. Do not rub the injection site. If necessary, apply a band-aid.

If you have been prescribed a dose of 140 mg and are using two Aimovig 70 mg syringes, repeat the steps from 1(D) to 4 with the second syringe to administer the full dose.

Country of registration
Active substance
Prescription required
Yes
Composition
Sacarosa (65 mg/ml mg), Hidroxido de sodio (e 524) (CSP MOL mg)
This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.

Talk to a doctor online

Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.

5.01 review
Doctor

Anna Moret

Dermatology18 years of experience

Dr. Anna Moret is a board-certified dermatologist and dermatovenereologist. She specialises in adult and pediatric dermatology, venereology, aesthetic skin care, and general medicine. Her consultations are evidence-based and tailored to each patient’s dermatological needs.

Dr. Moret provides expert evaluation and treatment for: • Skin conditions such as eczema, acne, rosacea, dermatitis, and psoriasis • Hair and scalp issues including hair loss, dandruff, and seborrheic dermatitis • Pediatric skin problems — from newborns to adolescents • Sexually transmitted infections (STIs) and dermatovenereology • Aesthetic concerns: skin ageing, non-invasive cosmetic treatments • Skin allergies and hypersensitivity reactions • Mole checks, lesion evaluation, and skin cancer screening • Skincare advice and personalised cosmeceutical routines

Combining dermatology with general medical knowledge, Dr. Moret offers comprehensive care that addresses both skin health and underlying conditions. She also holds certification from the Canadian Board of Aesthetic Medicine, ensuring an internationally aligned approach to aesthetic dermatology.

CameraBook a video appointment
5.05 reviews
Doctor

Alina Tsurkan

Family medicine12 years of experience

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including: • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections • Chronic diseases: hypertension, diabetes, thyroid disorders, elevated cholesterol, weight management • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness • Women’s health: menstrual irregularities, perimenopausal symptoms, preventive screening • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance

She also provides: • IMT medical certificates for driving licence exchange in Portugal • Personalised preventive care and wellness consultations • Interpretation of test results and medical reports • Follow-up care and medication review • Support in managing multiple coexisting conditions • Remote prescription management and medical documentation

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

CameraBook a video appointment
5.04 reviews
Doctor

Andrei Popov

General medicine6 years of experience

Dr. Andrei Popov is a licensed pain management specialist and general practitioner based in Spain. He provides expert online care for adults dealing with both chronic and acute pain, as well as a wide range of everyday health concerns.

He specialises in diagnosing and treating pain conditions that affect quality of life, including: • Chronic pain lasting more than 3 months • Migraines and recurring headaches • Neck, back, lower back, and joint pain • Post-traumatic pain following injury or surgery • Nerve-related pain, fibromyalgia, and neuralgia In addition to pain management, Dr. Popov helps patients with: • Respiratory infections (colds, bronchitis, pneumonia) • High blood pressure and metabolic conditions such as diabetes • Preventive care and routine health check-ups

Online consultations last up to 30 minutes and include a detailed symptom review, personalised treatment planning, and medical follow-up when needed.

Dr. Popov’s approach is rooted in evidence-based medicine, combined with individualised care tailored to each patient’s history, lifestyle, and clinical needs.

CameraBook a video appointment
5.03 reviews
Doctor

Yevgen Yakovenko

General surgery11 years of experience

Dr. Yevhenii Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise: • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan. • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions. • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies. • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries. • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required. • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up. • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data. • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications: • 12+ years of clinical experience in university hospitals in Germany and Spain • International education: Ukraine – Germany – Spain • Member of the German Society of Surgeons (BDC) • Certified in radiological diagnostics and robotic surgery • Active participant in international medical conferences and research

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

CameraBook a video appointment
See all doctors

Stay informed and save on care

Get health tips, platform updates, and exclusive promos for subscribers.

Follow us on social media
FacebookInstagramTikTok